Richard J. Sové - Concepedia

Author

Richard J. Sové

Johns Hopkins University ORCID

Also Known As

R.J. Sove, Richard J Sove, Richard J Sové, Richard J. Sove, Richard J. Sové, Richard Sove, Sove, Richard J.

Publications

623

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center Western University Boehringer Ingelheim (United States)

About

Richard J. Sové is an author at Johns Hopkins University specializing in medicine, immunology, and systems biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	255
2	Engineering	2	2	118
3	Cell Biology	2	2	118
4	Biology	1	1	87
5	Cellular Physiology	1	1	62

Richard J. Sové

Publications

594

Citations

H-Index

Page 1

	Year	Citations
Rapid desiccation hardening changes the cuticular hydrocarbon profile of Drosophila melanogaster Joseph R. Stinziano, Richard J. Sové, Howard D. Rundle, Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology BiologyDrosophila MelanogasterDevelopmental BiologyDevelopmental GeneticsGenetics	2014	87
A mechanistic integrative computational model of macrophage polarization: Implications in human pathophysiology Chen Zhao, Adam C. Mirando, Richard J. Sové, PLoS Computational Biology Environmental SignalingEngineeringMacrophage Phenotypic PolarizationImmunologyImmune System	2019	62
QSP‐IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno‐Oncology Applications Richard J. Sové, Mohammad Jafarnejad, Chen Zhao, CPT Pharmacometrics & Systems Pharmacology	2020	56
Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model Álvaro Ruiz-Martínez, Chang Gong, Hanwen Wang, PLoS Computational Biology EngineeringImmunologySpatial Agent-based ModelBiological MicroenvironmentsImmunoediting	2022	56
Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer Hanwen Wang, Huilin Ma, Richard J. Sové, Journal for ImmunoTherapy of Cancer	2021	52
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors Hanwen Wang, Richard J. Sové, Mohammad Jafarnejad, Frontiers in Bioengineering and Biotechnology Systems PharmacologyVirtual Clinical TrialBreast OncologyOncologyCancer Immunosurveillance	2020	50
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model Huilin Ma, Hanwen Wang, Richard J. Sové, Journal for ImmunoTherapy of Cancer	2020	49
A data-driven computational model enables integrative and mechanistic characterization of dynamic macrophage polarization Chen Zhao, Thalyta X. Medeiros, Richard J. Sové, iScience	2021	44
Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model Richard J. Sové, Babita K. Verma, Hanwen Wang, Journal for ImmunoTherapy of Cancer	2022	44
A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid Tumor Huilin Ma, Hanwen Wang, Richard J. Sové, The AAPS Journal	2020	43

Page 1